UK Oncology Forum

Dear Colleague

Unfortunately, the ACP has now had to cancel the Town Hall meeting, scheduled at the forthcoming UK Oncology Forum. The committee apologise for any inconvenience caused.

However – the UK Oncology Forum Faculty is excited to inform you that the meeting has been replaced with a new and very interesting Rapid Diagnostic Services Session, chaired by Dr Saoirse Dolly.

The UK Oncology forum is proud to showcase this inaugural meeting – highlighting the Rapid Diagnostic Services (RDS) for patients with non-site specific symptoms (NSS). Patients with NSS (such as weight loss, fatigue or pain) generally do not fit the standard two week rule (2WW) referral criteria and often bounce around systems and take longer to get diagnosed and treated.

Rapid Diagnostic Clinics (RDCs) provide a NSS 2WW referral route. These are being expanded across the Country with the aim of providing personalised, coordinated diagnostics to facilitate earlier cancer diagnosis and fast-track care. As well as reducing geographic differences in access to diagnostics. This session aims to bring primary care, diagnosticians, oncologists, radiologists and nurse practitioners together to share experiences in the development of the RDS and combine thinking on future developments and innovation.

Potential themes include:
1. RDS overview
RDC referral processes, filter function tests, pathway, alignment with cancer waiting times.
Clinical outcomes (present SEL RDC paper) with a focus on elderly, medically complex patients and mental health.
2. The RDS/re-direct
The vision – one referral, fluidity of care and improved patient journey. Process of re-directing patients between NSS and site specific (SS) pathways.
Options of front and back end redirects from other pathways
Present SEL data on volume of re-referrals from SS 2WW pathways and evaluation of the SEL lower GI back end pathway
Different models – ? involve greater manchester team where they use the upfront re-directs. Ernie on the AOS focused RDC model
3. Sustainability and service expansion
Overcoming health inequalities, NHSE typologies, workforce, financial effectiveness of the service
4. Innovation
Research opportunities, development, clinical trials

The session will take place Thursday 16th June 10:30hrs – 11:45hrs to register for the UK Oncology Forum (which has FREE registration and is CME accredited) please go to:
www.oncology-forum.co.uk/register

Best wishes
The UK Oncology Forum
PS please feel free to share with your colleagues

Latest News

By SHBN on 8th April 2026

SHBN Webinar – Safer Handling of Hazardous Medicinal Products: Evidence, Practice and Policy Change

This session will bring together research and policy perspectives to explore the current evidence base, the practical realities faced by healthcare professionals, and the policy considerations shaping future improvements in…

Read article
By BOPA Pharmacy Technician Subcommittee on 7th April 2026

Sharing Best Practice of BOPA Member Sarah Goman (Senior Pharmacy Technician) – New Pharmacy Patient Information Animations Launched at Velindre University NHS Trust

New Pharmacy Patient Information Animations Launched! – Velindre University NHS Trust Sarah Goman, Pharmacy Patient Education Team Lead and the driving force behind these videos, said: “We wanted to make…

Read article
By Caoimhe Keenan on 7th April 2026

APTUK joins BOPA and PASG in Pharmacy Workforce Position Statement on Safer Handling of Hazardous SACT Drugs

Dear colleagues, We are pleased to announce that the Association of Pharmacy Technicians UK (APTUK) has now formally joined the British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) in endorsing the…

Read article
By BOPA Committee on 7th April 2026

Launch of the BOPA Initial Training Programme for Cancer Care – Clinical Pharmacy

Dear BOPA Members, We are pleased to announce the launch of the BOPA Initial Training Programme for Cancer Care – Clinical Pharmacy. This programme has been developed to support the standardisation…

Read article